Interested applicants are required to submit an LOI. LOIs are accepted on a rolling basis through March 4, 2022 @ 5pm ET.

Funding Details

In this cycle, the IMPACT Collaboratory will fund up to five 1-year awards for pilot pragmatic clinical trials (ePCTs) that test non-pharmacological interventions embedded in health care system(s) for people living with AD/ADRD and their care partners. Pilot Studies will be funded for up to $175,000 in direct costs for a maximum of 12-months. For more information, please see our Pilot Grants Program page.

The goal of the pilot projects is to generate the preliminary data necessary to design and conduct a future full-scale Stage IV effectiveness ePCT (based on the NIH Stage Model) funded through other grant mechanisms (NIH or other sources)

The IMPACT Collaboratory will consider all applications for pilot ePCTs that evaluate non-pharmacological interventions to improve the care of people living with AD/ADRD and their care partners. This grant cycle will prioritize applications for interventions in these populations that aim to:

• Improve care through behavioral economics “nudge” interventions;
• Reduce inequities in health care;
• Reduce potentially inappropriate medications through de-prescribing; or
• Improve care in emergency departments.